The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $61.40

Today's change+0.40 +0.66%
Updated December 9 4:02 PM EST. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $61.40

Today's change+0.40 +0.66%
Updated December 9 4:02 PM EST. Delayed by at least 15 minutes.

USANA Health Sciences Inc up (U.S.)$0.40

USANA Health Sciences Inc closed up Friday by (U.S.)$0.40 or 0.66% to (U.S.)$61.40. Over the last five days, shares have gained 2.42%, but are down 3.87% for the last year to date. Shares have underperformed the S&P 500 by 17.54% during the last year.

Key company metrics

  • Open(U.S.) $61.00
  • Previous close(U.S.) $61.00
  • High(U.S.) $61.90
  • Low(U.S.) $60.90
  • Bid / Ask-- / --
  • YTD % change-3.87%
  • Volume139,147
  • Average volume (10-day)124,046
  • Average volume (1-month)127,083
  • Average volume (3-month)157,521
  • 52-week range(U.S.) $46.00 to (U.S.) $75.00
  • Beta1.12
  • Trailing P/E15.21×
  • P/E 1 year forward15.11×
  • Forward PEG1.51×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.04
Updated December 9 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.36%

Based on its net profit margin of 10.36%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.11%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedOct 01, 201610/01/2016Jul 02, 201607/02/2016Apr 02, 201604/02/2016Jan 02, 201601/02/2016
Revenue254259240233
Total other revenue--------
Total revenue254259240233
Gross profit209213198192
Total cost of revenue45464340
Total operating expense218221207197
Selling / general / administrative173175164157
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income36373435
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax36383336
Income after tax30262224
Income tax, total6121112
Net income30262224
Total adjustments to net income--------
Net income before extra. items30262224
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items30262224
Inc. avail. to common incl. extra. items30262224
Diluted net income30262224
Dilution adjustment--------
Diluted weighted average shares25252526
Diluted EPS excluding extraordinary itemsvalue per share1.201.030.890.92
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.201.030.890.92